Peripheral CD4+CD25hiCD127low regulatory T cells are increased in patients with gastrointestinal cancer
J Qiu, W Shi, J Zhang, Q Gao, L Feng, Z Zhuang - BMC gastroenterology, 2023 - Springer
Abstract Background Regulatory T cells (Tregs) play an important role in regulation of
immune response and immunologic tolerance in cancer. Gastrointestinal cancer is still a …
immune response and immunologic tolerance in cancer. Gastrointestinal cancer is still a …
Immunohistochemical Expression of Immune Checkpoints; CTLA-4, LAG3, and TIM-3 in Cancer Cells and Tumor-infiltrating Lymphocytes (TILs) in Colorectal …
DI Abdelrahman, I Elhasadi, A Anbaig… - Applied …, 2024 - journals.lww.com
Background: Colorectal cancer is considered the third most prevalent cancer in both sexes.
Immune checkpoint receptors that regulate T-cell response, stimulation, and development …
Immune checkpoint receptors that regulate T-cell response, stimulation, and development …
Identification of CD8+ CD25+ Foxp3+ suppressive T cells in colorectal cancer tissue
Background: The antitumoral immune response is one determinant of colorectal cancer
(CRC) outcome. Recent work suggests that Foxp3+ CD25+ CD4+ regulatory T cells (T4reg) …
(CRC) outcome. Recent work suggests that Foxp3+ CD25+ CD4+ regulatory T cells (T4reg) …
Tumor-infiltrating CD39+ γδTregs are novel immunosuppressive T cells in human colorectal cancer
Tumor microenvironment (TME) promotes immune suppression through recruiting and
expanding suppressive immune cells such as regulatory T cells (Tregs) to facilitate cancer …
expanding suppressive immune cells such as regulatory T cells (Tregs) to facilitate cancer …
Tumor infiltrating regulatory T cells in sporadic and colitis-associated colorectal cancer: the red little riding hood and the wolf
Regulatory T cells represent a class of specialized T lymphocytes that suppress unwanted
immune responses and size the activation of the immune system whereby limiting collateral …
immune responses and size the activation of the immune system whereby limiting collateral …
Tumor-infiltrating immune cells act as a marker for prognosis in colorectal cancer
L Ye, T Zhang, Z Kang, G Guo, Y Sun, K Lin… - Frontiers in …, 2019 - frontiersin.org
Tumor-infiltrating immune cells (TIICs) play essential roles in cancer development and
progression. However, the association of TIICs with prognosis in colorectal cancer (CRC) …
progression. However, the association of TIICs with prognosis in colorectal cancer (CRC) …
Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer
E Timperi, I Pacella, V Schinzari, C Focaccetti… - …, 2016 - Taylor & Francis
Tregs can contribute to tumor progression by suppressing antitumor immunity. Exceptionally,
in human colorectal cancer (CRC), Tregs are thought to exert beneficial roles in controlling …
in human colorectal cancer (CRC), Tregs are thought to exert beneficial roles in controlling …
[HTML][HTML] Intratumoral density of regulatory T cells is a predictor of host immune response and chemotherapy response in colorectal cancer
Regulatory T cells (Tregs) are a subset of CD4+ T lymphocytes known to dampen the host
immune response against cancer cells. Within the tumor microenvironment, Tregs are potent …
immune response against cancer cells. Within the tumor microenvironment, Tregs are potent …
Single-cell analysis reveals characterization of infiltrating T cells in moderately differentiated colorectal cancer
X Yang, Q Qi, Y Pan, Q Zhou, Y Wu, J Zhuang… - Frontiers in …, 2021 - frontiersin.org
Objective This study aimed to characterize the tumor-infiltrating T cells in moderately
differentiated colorectal cancer. Methods Using single-cell RNA sequencing data of isolated …
differentiated colorectal cancer. Methods Using single-cell RNA sequencing data of isolated …
A detailed flow cytometric analysis of immune activity profiles in molecular subtypes of colorectal cancer
X Li, A Ling, TG Kellgren, M Lundholm… - Cancers, 2020 - mdpi.com
Simple Summary Colorectal cancer is one of the deadliest cancers worldwide, with around
40% of patients dying from distant metastasis. Tumour immune cell infiltration has powerful …
40% of patients dying from distant metastasis. Tumour immune cell infiltration has powerful …